Literature DB >> 12636162

Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate.

Sofia Faraasen1, János Vörös, Gábor Csúcs, Marcus Textor, Hans P Merkle, Elke Walter.   

Abstract

PURPOSE: The purpose of this study was to demonstrate specific receptor-mediated targeting of phagocytes by functional surface coatings of microparticles, shielding from nonspecific phagocytosis and allowing ligand-specific interactions via molecular recognition.
METHODS: Coatings of the comb polymer poly(L-lysine)-g-poly(ethylene glycol) (PLL-g-PEG) were investigated for potential to inhibit 1) nonspecific spreading of human blood-derived macrophages (MOs) and dendritic cells (DCs) on glass and 2) nonspecific phagocytosis of PLL-g-PEG-coated, carboxylated polystyrene (PS) or biodegradable poly(D,L-lactide-co-glycolide) (PLGA) microspheres. Coating was performed by adsorption of positively charged PLL-g-PEG on negatively charged microparticles or plasma-cleaned glass through electrostatic interaction. The feasibility of ligand-specific interactions was tested with a model ligand, RGD, conjugated to PEG chains of PLL-g-PEG to form PLL-g-PEG-RGD and compared with inactive ligand conjugate, PLL-g-PEG-RDG.
RESULTS: Coatings with PLL-g-PEG largely impaired the adherence and spreading of MOs and DCs on glass. The repellent character of PLL-g-PEG coatings drastically reduced phagocytosis of coated PS and PLGA microparticles to 10% in presence of serum. With both MOs and DCs, we observed ligand-specific interactions with PLL-g-PEG-RGD coatings on glass and PS and PLGA microspheres. Ligand specificity was abolished when using inactive ligand conjugate PLL-g-PEG-RDG, whereas repellency of coating was maintained.
CONCLUSIONS: Coatings of PLL-g-PEG-ligand conjugates provide a novel technology for ligand specific targeting of microspheres to MOs and DCs while reducing nonspecific phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636162     DOI: 10.1023/a:1022366921298

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  46 in total

1.  Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.

Authors:  E Walter; K Moelling; J Pavlovic; H P Merkle
Journal:  J Control Release       Date:  1999-09-20       Impact factor: 9.776

2.  OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway.

Authors:  P Jeannin; T Renno; L Goetsch; I Miconnet; J P Aubry; Y Delneste; N Herbault; T Baussant; G Magistrelli; C Soulas; P Romero; J C Cerottini; J Y Bonnefoy
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

Review 3.  Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

Authors:  Fakhrul Ahsan; Isabel P Rivas; Mansoor A Khan; Ana I Torres Suarez
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

4.  Marked hypotensive and blood flow-increasing effects of a new lipo-PGE(1) (lipo-AS013) due to vascular wall targeting.

Authors:  R Igarashi; M Takenaga; J Takeuchi; A Kitagawa; K Matsumoto; Y Mizushima
Journal:  J Control Release       Date:  2001-04-02       Impact factor: 9.776

5.  Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages.

Authors:  L Illum; L O Jacobsen; R H Müller; E Mak; S S Davis
Journal:  Biomaterials       Date:  1987-03       Impact factor: 12.479

6.  RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion.

Authors:  Stephanie VandeVondele; Janos Vörös; Jeffrey A Hubbell
Journal:  Biotechnol Bioeng       Date:  2003-06-30       Impact factor: 4.530

7.  Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.

Authors:  S M Moghimi; C J Porter; I S Muir; L Illum; S S Davis
Journal:  Biochem Biophys Res Commun       Date:  1991-06-14       Impact factor: 3.575

8.  Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

Authors:  L Thiele; B Rothen-Rutishauser; S Jilek; H Wunderli-Allenspach; H P Merkle; E Walter
Journal:  J Control Release       Date:  2001-09-11       Impact factor: 9.776

9.  Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro.

Authors:  M A Tracy; K L Ward; L Firouzabadian; Y Wang; N Dong; R Qian; Y Zhang
Journal:  Biomaterials       Date:  1999-06       Impact factor: 12.479

10.  Influence of block copolymers on the adsorption of plasma proteins to microspheres.

Authors:  M E Norman; P Williams; L Illum
Journal:  Biomaterials       Date:  1993-02       Impact factor: 12.479

View more
  18 in total

1.  Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.

Authors:  Samantha Jilek; Michael Ulrich; Hans P Merkle; Elke Walter
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

Review 2.  Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.

Authors:  Benjamin G Keselowsky; Chang Qing Xia; Michael Clare-Salzler
Journal:  Hum Vaccin       Date:  2011-01-01

Review 3.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

4.  Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.

Authors:  Athulya Aravind; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

Review 5.  Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications.

Authors:  Amjad Ali Khan; Khaled S Allemailem; Saleh A Almatroodi; Ahmed Almatroudi; Arshad Husain Rahmani
Journal:  3 Biotech       Date:  2020-03-10       Impact factor: 2.406

6.  Effect of partial PEGylation on particle uptake by macrophages.

Authors:  Lucero Sanchez; Yi Yi; Yan Yu
Journal:  Nanoscale       Date:  2016-12-02       Impact factor: 7.790

7.  Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Authors:  Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Mol Pharm       Date:  2012-11-20       Impact factor: 4.939

8.  Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating.

Authors:  Guilin Wang; Kevin Siggers; Sufeng Zhang; Hongxing Jiang; Zhenghe Xu; Ronald F Zernicke; John Matyas; Hasan Uludağ
Journal:  Pharm Res       Date:  2008-08-15       Impact factor: 4.200

9.  Molecular factors in dendritic cell responses to adsorbed glycoconjugates.

Authors:  Nathan A Hotaling; Richard D Cummings; Daniel M Ratner; Julia E Babensee
Journal:  Biomaterials       Date:  2014-04-16       Impact factor: 12.479

10.  Facile Synthesis of PEGylated PLGA Nanoparticles Encapsulating Doxorubicin and its In Vitro Evaluation as Potent Drug Delivery Vehicle.

Authors:  Rajiv Kumar; Apurva Kulkarni; Jude Nabulsi; Dattatri K Nagesha; Robert Cormack; Mike G Makrigiorgos; Srinivas Sridhar
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.